Temporal changes in the outcomes of patients with diabetes mellitus undergoing percutaneous coronary intervention in the National Heart, Lung, and Blood Institute dynamic registry

American Heart Journal

Volumn 161, Issue 2, 2011, Pages

  Holper, Elizabeth M ^a   Abbott, J Dawn ^b   Mulukutla, Suresh ^c   Vlachos, Helen ^c   Selzer, Faith ^c   McGuire, Darren ^a   Faxon, David P ^d   Laskey, Warren ^e   Srinivas, Vankeepuram S ^f   Marroquin, Oscar C ^c   Jacobs, Alice K ^g  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^f MONTEFIORE MEDICAL CENTER   (United States)

^g BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; ORAL ANTIDIABETIC AGENT;

ARTICLE; CHRONOLOGY; COHORT ANALYSIS; DEMOGRAPHY; DIABETES MELLITUS; DIABETIC PATIENT; FEMALE; HAZARD RATIO; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NATIONAL HEALTH ORGANIZATION; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REGISTER; TREATMENT OUTCOME;

EID: 79851490893     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.11.004     Document Type: Article

References (20)

1. Wild S., Roglic G., and Green A. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 Diabetes Care 27 2004 1047 1053 (Pubitemid 38579764)
2. Abizaid A., Kornowski R., and Mintz G. The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation J Am Coll Cardiol 32 1998 584 589 (Pubitemid 28435240)
3. Matthew V., Gersh B., and Williams B. Outcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention in the current era: a report from the Prevention of REStenosis with Tranilast and its outcomes (PRESTO) trial Circulation 109 2004 476 480 (Pubitemid 38168509)
4. Kip K.E., Faxon D.P., and Detre K.M. Coronary angioplasty in diabetic patients: the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry Circulation 94 1996 1818 1825 (Pubitemid 26349292)
5. Barsness G.W., Peterson E., and Ohman E. Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty Circulation 96 1997 2551 2556 (Pubitemid 27451345)
6. Rozenman Y., Sapoznikov D., and Gotsman M. Restenosis and progression of coronary disease after balloon angioplasty in patients with diabetes mellitus Clin Cardiol 2000 890 894
7. Elezi S., Kastrati A., and Pache J. Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement J Am Coll Cardiol 32 1998 1866 1873 (Pubitemid 29010448)
8. Joseph T., Fajadet J., and Jordan C. Coronary stenting in diabetics: immediate and mid-term clinical outcome Catheter Cardiovasc Interv 47 1999 279 284
9. Williams D.O., Holubkov R., and Yeh W. Percutaneous coronary intervention in the current era compared with 1985-1986. The National Heart, Lung, and Blood Institute Registries Circulation 102 2000 2945 2951
10. Arcaro G., Cretti A., and Balzano S. Insulin causes endothelial dysfunction in humans: sites and mechanisms Circulation 105 2002 576 582 (Pubitemid 34123431)
11. Nishimoto Y., Miyazaki Y., and Toki Y. Enhanced secretion of insulin plays a role in the development of atherosclerosis and restenosis of coronary arteries: elective percutaneous transluminal coronary angioplasty in patients with effort angina J Am Coll Cardiol 1998 1998 1624 1629 (Pubitemid 28545200)
12. Brooks M.M., Frye R.L., and Genuth S. Hypotheses, design, and methods for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial Am J Cardiol 97 2006 9 19 (Pubitemid 43927485)
13. Chaitman B.R., Hardison R.M., and Adler D. Bypass Angioplasty Revascularization Investigation 2 Diabetes Study Group. The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and myocardial infarction Circulation 120 2009 2529 2540
14. Stein B., Weintraub W.S., and Gebhart S.S.P. Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty Circulation 91 1995 979 989
15. Mathew V., Frye R.L., and Lennon R. Comparison of survival after successful percutaneous coronary intervention of patients with diabetes mellitus receiving insulin versus those receiving only diet and/or oral hypoglycemic agents Am J Cardiol 93 2004 399 403 (Pubitemid 38221344)
16. Marso S., Giorgi L., and Johnson W. Diabetes mellitus is associated with a shift in the temporal risk profile of inhospital death after percutaneous coronary intervention: an analysis of 25,223 patients over 20 years Am Heart J 145 2003 270 277 (Pubitemid 36207948)
17. Freeman A., Abbott J., and Jacobs A. Marked improvements in outcomes of contemporary percutaneous coronary intervention in patients with diabetes mellitus J Interv Cardiol 19 2006 475 482 (Pubitemid 44722237)
18. Mulukutla S.R., Vlachos H.A., and Marroquin O.C. Impact of drug-eluting stents among insulin-treated diabetic patients: a report from the National Heart, Lung, and Blood Institute Dynamic Registry J Am Coll Cardiol Intv 1 2008 139 147 (Pubitemid 351506563)
19. Sabate M., Jimenez-Quevedo P., Angiolillo D.J. for the DI Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the Diabetes and Sirolimus-Eluting Stent (DIABETES) trial Circulation 112 2005 2175 2183 (Pubitemid 41475813)
20. Hermiller J.B., Raizner A., and Cannon L. Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus: the TAXUS-IV trial J Am Coll Cardiol 45 2005 1172 1179 (Pubitemid 40523133)